FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385768614> ?p ?o ?g. }

• W4385768614 endingPage "3398" @default.
• W4385768614 startingPage "3381" @default.
• W4385768614 abstract "Elucidation of the oncogenic role of SLC35A2 in human tumors and the potential function and clinical significance in breast cancer.Pan-cancer analysis was performed via various bioinformatics tools to explain the pathogenic role of SLC35A2. A prognostic nomogram was also developed based on the SLC35A2 expression and clinicopathological characteristics in breast cancer patients. In addition, the role of SLC35A2 was validated in breast cancer by in vivo and in vitro experiments.SLC35A2 expression is increased in 27 tumor types, and its high expression is substantially correlated with poor prognosis in patients with a variety of cancers. Receiver operating characteristic (ROC) curves showed that SLC35A2 expression levels could accurately distinguish most tumor tissues from normal tissues. High SLC35A2 expression was linked to increased immune infiltration in myeloid-derived suppressor cells (MDSC), as well as immune checkpoints, ferroptosis-related genes, tumor mutational burden (TMB), and microsatellite instability (MSI). SLC35A2 may be involved in tumorigenesis by regulating the glycosylation process. Furthermore, multivariate Cox analysis showed that SLC35A2 was an independent prognostic factor for breast cancer. And the nomogram model had good predictive accuracy for the prognosis of breast cancer patients. Meanwhile, cellular experiments demonstrated that knockdown of SLC35A2 could significantly inhibit the proliferation, migration and invasion of breast cancer cells, while increasing the protein level of E-cadherin and decreasing N-cadherin. A nude mouse xenograft model showed that inhibition of SLA35A2 expression could significantly inhibit tumor growth.SLC35A2 has good diagnostic and prognostic values in multiple cancers and is closely related to tumor immune infiltration. In addition, SLA35A2 as an oncogene in breast cancer may be involved in the progression of epithelial mesenchymal transition (EMT)." @default.
• W4385768614 created "2023-08-12" @default.
• W4385768614 creator A5010532818 @default.
• W4385768614 creator A5010833015 @default.
• W4385768614 creator A5028055208 @default.
• W4385768614 creator A5038808458 @default.
• W4385768614 creator A5055398648 @default.
• W4385768614 creator A5064009607 @default.
• W4385768614 creator A5083653846 @default.
• W4385768614 date "2023-08-01" @default.
• W4385768614 modified "2023-09-26" @default.
• W4385768614 title "Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer" @default.
• W4385768614 cites W1985102142 @default.
• W4385768614 cites W1993875664 @default.
• W4385768614 cites W2023094207 @default.
• W4385768614 cites W2338225276 @default.
• W4385768614 cites W2535295725 @default.
• W4385768614 cites W2568946517 @default.
• W4385768614 cites W2586097538 @default.
• W4385768614 cites W2800548003 @default.
• W4385768614 cites W2810168169 @default.
• W4385768614 cites W2889331482 @default.
• W4385768614 cites W2902245576 @default.
• W4385768614 cites W2903686952 @default.
• W4385768614 cites W2906067435 @default.
• W4385768614 cites W2912297206 @default.
• W4385768614 cites W2920326838 @default.
• W4385768614 cites W2937441321 @default.
• W4385768614 cites W2943005115 @default.
• W4385768614 cites W2943074432 @default.
• W4385768614 cites W2946657092 @default.
• W4385768614 cites W3010191570 @default.
• W4385768614 cites W3023623407 @default.
• W4385768614 cites W3045029533 @default.
• W4385768614 cites W3083844715 @default.
• W4385768614 cites W3107527779 @default.
• W4385768614 cites W3119404665 @default.
• W4385768614 cites W3129101074 @default.
• W4385768614 cites W3157770914 @default.
• W4385768614 cites W3162350134 @default.
• W4385768614 cites W3208215773 @default.
• W4385768614 cites W3217512418 @default.
• W4385768614 cites W4200377407 @default.
• W4385768614 cites W4246312149 @default.
• W4385768614 cites W4248942306 @default.
• W4385768614 cites W4283707775 @default.
• W4385768614 cites W4294992918 @default.
• W4385768614 cites W4308882387 @default.
• W4385768614 cites W4310565735 @default.
• W4385768614 cites W4313474720 @default.
• W4385768614 cites W4318407541 @default.
• W4385768614 doi "https://doi.org/10.2147/jir.s419994" @default.
• W4385768614 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37593196" @default.
• W4385768614 hasPublicationYear "2023" @default.
• W4385768614 type Work @default.
• W4385768614 citedByCount "0" @default.
• W4385768614 crossrefType "journal-article" @default.
• W4385768614 hasAuthorship W4385768614A5010532818 @default.
• W4385768614 hasAuthorship W4385768614A5010833015 @default.
• W4385768614 hasAuthorship W4385768614A5028055208 @default.
• W4385768614 hasAuthorship W4385768614A5038808458 @default.
• W4385768614 hasAuthorship W4385768614A5055398648 @default.
• W4385768614 hasAuthorship W4385768614A5064009607 @default.
• W4385768614 hasAuthorship W4385768614A5083653846 @default.
• W4385768614 hasBestOaLocation W43857686141 @default.
• W4385768614 hasConcept C118646709 @default.
• W4385768614 hasConcept C121608353 @default.
• W4385768614 hasConcept C126322002 @default.
• W4385768614 hasConcept C143998085 @default.
• W4385768614 hasConcept C173396325 @default.
• W4385768614 hasConcept C203014093 @default.
• W4385768614 hasConcept C34626388 @default.
• W4385768614 hasConcept C502942594 @default.
• W4385768614 hasConcept C530470458 @default.
• W4385768614 hasConcept C54355233 @default.
• W4385768614 hasConcept C555283112 @default.
• W4385768614 hasConcept C71924100 @default.
• W4385768614 hasConcept C81885089 @default.
• W4385768614 hasConcept C86803240 @default.
• W4385768614 hasConcept C8891405 @default.
• W4385768614 hasConceptScore W4385768614C118646709 @default.
• W4385768614 hasConceptScore W4385768614C121608353 @default.
• W4385768614 hasConceptScore W4385768614C126322002 @default.
• W4385768614 hasConceptScore W4385768614C143998085 @default.
• W4385768614 hasConceptScore W4385768614C173396325 @default.
• W4385768614 hasConceptScore W4385768614C203014093 @default.
• W4385768614 hasConceptScore W4385768614C34626388 @default.
• W4385768614 hasConceptScore W4385768614C502942594 @default.
• W4385768614 hasConceptScore W4385768614C530470458 @default.
• W4385768614 hasConceptScore W4385768614C54355233 @default.
• W4385768614 hasConceptScore W4385768614C555283112 @default.
• W4385768614 hasConceptScore W4385768614C71924100 @default.
• W4385768614 hasConceptScore W4385768614C81885089 @default.
• W4385768614 hasConceptScore W4385768614C86803240 @default.
• W4385768614 hasConceptScore W4385768614C8891405 @default.
• W4385768614 hasLocation W43857686141 @default.
• W4385768614 hasLocation W43857686142 @default.
• W4385768614 hasOpenAccess W4385768614 @default.

• next